Baidu
map

AZ的肺癌药物Tagrisso在欧洲获准作为一线用药

2018-05-01 MedSci MedSci原创

欧洲的监管顾问支持阿斯利康公司的肺癌药物Tagrisso作为一线用药的批准。欧洲药品管理局人用药品委员会(CHMP)建议扩大该药品的标签,以包括表皮生长因子受体(EGFR)突变的成人局部晚期或转移性非小细胞肺癌(NSCLC)的成人一线治疗。该研究的首席医疗官Sean Bohen指出:"该积极的建议承认Tagrisso的osimertinib具有欧洲EGFR突变NSCLC患者的一线治疗新标准的潜力。


欧洲的监管顾问支持阿斯利康公司的肺癌药物Tagrisso作为一线用药的批准。

欧洲药品管理局人用药品委员会(CHMP)建议扩大该药品的标签,以包括表皮生长因子受体(EGFR)突变的成人局部晚期或转移性非小细胞肺癌NSCLC)的成人一线治疗。

该研究的首席医疗官Sean Bohen指出:"该积极的建议承认Tagrisso的osimertinib具有欧洲EGFR突变NSCLC患者的一线治疗新标准的潜力。"

"它反映了FLAURA数据的优势,显示Tagrisso在所有预先设定的患者亚组中,包括那些有或没有中枢神经系统的患者,其EGFR-TKI比较组在改善无进展生存期方面具有显着的统计学差异和临床意义。"

根据这数据,在美国获得了批准。数据显示服用Tagrisso的患者的无进展生存期为18.9个月,而接受标准护理的患者的无进展生存期为10.2个月,而客观缓解率分别为80%与76%。

在日内瓦举行的欧洲肺癌会议(ELCC)上对FLAURA结果进行的一项新分析也显示,药物对EGFR酪氨酸激酶抑制剂(TKIs)的PFS益处在整个后续进展中持续存在。

Tagrisso最初被全球几个国家批准为EGFR T790M突变阳性晚期NSCLC患者的二线治疗药物。

此外,CHMP还建议扩大UCB Pharma SA的Cimzia(certolizumab pegol)治疗适用于全身治疗的成年人的斑块型银屑病的适应证; Amgen的Prolia (sumab)与长期系统性糖皮质激素治疗引起的骨质流失增加了骨折的风险相关; Bristol-Myers Squibb的Sprycel(达沙替尼)用于治疗新诊断Ph + CML慢性期或Ph + CML-CP耐药或不耐受包括伊马替尼在内的儿科患者; 和辉瑞公司的Xeljanz(托法替尼)联合甲氨蝶呤治疗某些患者的活动性银屑病关节炎。


此文系梅斯医学(MedSci)原创整理编译,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (8)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1714781, encodeId=9a4c1e14781c0, content=<a href='/topic/show?id=021230e312' target=_blank style='color:#2F92EE;'>#AZ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3073, encryptionId=021230e312, topicName=AZ)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Tue Oct 09 08:21:00 CST 2018, time=2018-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=313886, encodeId=ebdf313886d6, content=好的, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/BHHqJOYCGO2Qnoy0HvW6a8484LMTViaaTLQricqaDrrg5shY907vventGeHZZgj5mlobGntCxX1JqYBgoEhLePCw/132, createdBy=a4312343135, createdName=guicaiwei, createdTime=Thu May 10 20:37:02 CST 2018, time=2018-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=313219, encodeId=eb0631321996, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/BHHqJOYCGO2Qnoy0HvW6a8484LMTViaaTLQricqaDrrg5shY907vventGeHZZgj5mlobGntCxX1JqYBgoEhLePCw/132, createdBy=a4312343135, createdName=guicaiwei, createdTime=Tue May 08 20:33:41 CST 2018, time=2018-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=312604, encodeId=e1a43126048f, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/BHHqJOYCGO2Qnoy0HvW6a8484LMTViaaTLQricqaDrrg5shY907vventGeHZZgj5mlobGntCxX1JqYBgoEhLePCw/132, createdBy=a4312343135, createdName=guicaiwei, createdTime=Sun May 06 18:29:57 CST 2018, time=2018-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1339081, encodeId=b4be133908116, content=<a href='/topic/show?id=447663054f5' target=_blank style='color:#2F92EE;'>#欧洲#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63054, encryptionId=447663054f5, topicName=欧洲)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEKxsKDoOOFxGpMibw6lsQFUIicWt7kWGevkdgFhjiban1icD2JdIBmjVo7qX7aSlCSpiaia382nuLKiaI3Cg/132, createdBy=5c442500150, createdName=ms9474365431325850, createdTime=Thu May 03 01:21:00 CST 2018, time=2018-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1385799, encodeId=2ffe1385e99d2, content=<a href='/topic/show?id=77371e08996' target=_blank style='color:#2F92EE;'>#Tagrisso#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17089, encryptionId=77371e08996, topicName=Tagrisso)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dcaa509, createdName=tsing_hit, createdTime=Thu May 03 01:21:00 CST 2018, time=2018-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=311220, encodeId=0e92311220da, content=很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/BHHqJOYCGO2Qnoy0HvW6a8484LMTViaaTLQricqaDrrg5shY907vventGeHZZgj5mlobGntCxX1JqYBgoEhLePCw/132, createdBy=a4312343135, createdName=guicaiwei, createdTime=Wed May 02 07:43:06 CST 2018, time=2018-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=310976, encodeId=7c133109e6c2, content=学习了.长知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Tue May 01 11:37:16 CST 2018, time=2018-05-01, status=1, ipAttribution=)]
    2018-10-09 仁者大医
  2. [GetPortalCommentsPageByObjectIdResponse(id=1714781, encodeId=9a4c1e14781c0, content=<a href='/topic/show?id=021230e312' target=_blank style='color:#2F92EE;'>#AZ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3073, encryptionId=021230e312, topicName=AZ)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Tue Oct 09 08:21:00 CST 2018, time=2018-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=313886, encodeId=ebdf313886d6, content=好的, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/BHHqJOYCGO2Qnoy0HvW6a8484LMTViaaTLQricqaDrrg5shY907vventGeHZZgj5mlobGntCxX1JqYBgoEhLePCw/132, createdBy=a4312343135, createdName=guicaiwei, createdTime=Thu May 10 20:37:02 CST 2018, time=2018-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=313219, encodeId=eb0631321996, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/BHHqJOYCGO2Qnoy0HvW6a8484LMTViaaTLQricqaDrrg5shY907vventGeHZZgj5mlobGntCxX1JqYBgoEhLePCw/132, createdBy=a4312343135, createdName=guicaiwei, createdTime=Tue May 08 20:33:41 CST 2018, time=2018-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=312604, encodeId=e1a43126048f, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/BHHqJOYCGO2Qnoy0HvW6a8484LMTViaaTLQricqaDrrg5shY907vventGeHZZgj5mlobGntCxX1JqYBgoEhLePCw/132, createdBy=a4312343135, createdName=guicaiwei, createdTime=Sun May 06 18:29:57 CST 2018, time=2018-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1339081, encodeId=b4be133908116, content=<a href='/topic/show?id=447663054f5' target=_blank style='color:#2F92EE;'>#欧洲#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63054, encryptionId=447663054f5, topicName=欧洲)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEKxsKDoOOFxGpMibw6lsQFUIicWt7kWGevkdgFhjiban1icD2JdIBmjVo7qX7aSlCSpiaia382nuLKiaI3Cg/132, createdBy=5c442500150, createdName=ms9474365431325850, createdTime=Thu May 03 01:21:00 CST 2018, time=2018-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1385799, encodeId=2ffe1385e99d2, content=<a href='/topic/show?id=77371e08996' target=_blank style='color:#2F92EE;'>#Tagrisso#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17089, encryptionId=77371e08996, topicName=Tagrisso)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dcaa509, createdName=tsing_hit, createdTime=Thu May 03 01:21:00 CST 2018, time=2018-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=311220, encodeId=0e92311220da, content=很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/BHHqJOYCGO2Qnoy0HvW6a8484LMTViaaTLQricqaDrrg5shY907vventGeHZZgj5mlobGntCxX1JqYBgoEhLePCw/132, createdBy=a4312343135, createdName=guicaiwei, createdTime=Wed May 02 07:43:06 CST 2018, time=2018-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=310976, encodeId=7c133109e6c2, content=学习了.长知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Tue May 01 11:37:16 CST 2018, time=2018-05-01, status=1, ipAttribution=)]
    2018-05-10 guicaiwei

    好的

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1714781, encodeId=9a4c1e14781c0, content=<a href='/topic/show?id=021230e312' target=_blank style='color:#2F92EE;'>#AZ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3073, encryptionId=021230e312, topicName=AZ)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Tue Oct 09 08:21:00 CST 2018, time=2018-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=313886, encodeId=ebdf313886d6, content=好的, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/BHHqJOYCGO2Qnoy0HvW6a8484LMTViaaTLQricqaDrrg5shY907vventGeHZZgj5mlobGntCxX1JqYBgoEhLePCw/132, createdBy=a4312343135, createdName=guicaiwei, createdTime=Thu May 10 20:37:02 CST 2018, time=2018-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=313219, encodeId=eb0631321996, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/BHHqJOYCGO2Qnoy0HvW6a8484LMTViaaTLQricqaDrrg5shY907vventGeHZZgj5mlobGntCxX1JqYBgoEhLePCw/132, createdBy=a4312343135, createdName=guicaiwei, createdTime=Tue May 08 20:33:41 CST 2018, time=2018-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=312604, encodeId=e1a43126048f, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/BHHqJOYCGO2Qnoy0HvW6a8484LMTViaaTLQricqaDrrg5shY907vventGeHZZgj5mlobGntCxX1JqYBgoEhLePCw/132, createdBy=a4312343135, createdName=guicaiwei, createdTime=Sun May 06 18:29:57 CST 2018, time=2018-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1339081, encodeId=b4be133908116, content=<a href='/topic/show?id=447663054f5' target=_blank style='color:#2F92EE;'>#欧洲#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63054, encryptionId=447663054f5, topicName=欧洲)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEKxsKDoOOFxGpMibw6lsQFUIicWt7kWGevkdgFhjiban1icD2JdIBmjVo7qX7aSlCSpiaia382nuLKiaI3Cg/132, createdBy=5c442500150, createdName=ms9474365431325850, createdTime=Thu May 03 01:21:00 CST 2018, time=2018-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1385799, encodeId=2ffe1385e99d2, content=<a href='/topic/show?id=77371e08996' target=_blank style='color:#2F92EE;'>#Tagrisso#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17089, encryptionId=77371e08996, topicName=Tagrisso)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dcaa509, createdName=tsing_hit, createdTime=Thu May 03 01:21:00 CST 2018, time=2018-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=311220, encodeId=0e92311220da, content=很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/BHHqJOYCGO2Qnoy0HvW6a8484LMTViaaTLQricqaDrrg5shY907vventGeHZZgj5mlobGntCxX1JqYBgoEhLePCw/132, createdBy=a4312343135, createdName=guicaiwei, createdTime=Wed May 02 07:43:06 CST 2018, time=2018-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=310976, encodeId=7c133109e6c2, content=学习了.长知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Tue May 01 11:37:16 CST 2018, time=2018-05-01, status=1, ipAttribution=)]
    2018-05-08 guicaiwei

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1714781, encodeId=9a4c1e14781c0, content=<a href='/topic/show?id=021230e312' target=_blank style='color:#2F92EE;'>#AZ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3073, encryptionId=021230e312, topicName=AZ)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Tue Oct 09 08:21:00 CST 2018, time=2018-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=313886, encodeId=ebdf313886d6, content=好的, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/BHHqJOYCGO2Qnoy0HvW6a8484LMTViaaTLQricqaDrrg5shY907vventGeHZZgj5mlobGntCxX1JqYBgoEhLePCw/132, createdBy=a4312343135, createdName=guicaiwei, createdTime=Thu May 10 20:37:02 CST 2018, time=2018-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=313219, encodeId=eb0631321996, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/BHHqJOYCGO2Qnoy0HvW6a8484LMTViaaTLQricqaDrrg5shY907vventGeHZZgj5mlobGntCxX1JqYBgoEhLePCw/132, createdBy=a4312343135, createdName=guicaiwei, createdTime=Tue May 08 20:33:41 CST 2018, time=2018-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=312604, encodeId=e1a43126048f, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/BHHqJOYCGO2Qnoy0HvW6a8484LMTViaaTLQricqaDrrg5shY907vventGeHZZgj5mlobGntCxX1JqYBgoEhLePCw/132, createdBy=a4312343135, createdName=guicaiwei, createdTime=Sun May 06 18:29:57 CST 2018, time=2018-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1339081, encodeId=b4be133908116, content=<a href='/topic/show?id=447663054f5' target=_blank style='color:#2F92EE;'>#欧洲#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63054, encryptionId=447663054f5, topicName=欧洲)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEKxsKDoOOFxGpMibw6lsQFUIicWt7kWGevkdgFhjiban1icD2JdIBmjVo7qX7aSlCSpiaia382nuLKiaI3Cg/132, createdBy=5c442500150, createdName=ms9474365431325850, createdTime=Thu May 03 01:21:00 CST 2018, time=2018-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1385799, encodeId=2ffe1385e99d2, content=<a href='/topic/show?id=77371e08996' target=_blank style='color:#2F92EE;'>#Tagrisso#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17089, encryptionId=77371e08996, topicName=Tagrisso)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dcaa509, createdName=tsing_hit, createdTime=Thu May 03 01:21:00 CST 2018, time=2018-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=311220, encodeId=0e92311220da, content=很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/BHHqJOYCGO2Qnoy0HvW6a8484LMTViaaTLQricqaDrrg5shY907vventGeHZZgj5mlobGntCxX1JqYBgoEhLePCw/132, createdBy=a4312343135, createdName=guicaiwei, createdTime=Wed May 02 07:43:06 CST 2018, time=2018-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=310976, encodeId=7c133109e6c2, content=学习了.长知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Tue May 01 11:37:16 CST 2018, time=2018-05-01, status=1, ipAttribution=)]
    2018-05-06 guicaiwei

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1714781, encodeId=9a4c1e14781c0, content=<a href='/topic/show?id=021230e312' target=_blank style='color:#2F92EE;'>#AZ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3073, encryptionId=021230e312, topicName=AZ)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Tue Oct 09 08:21:00 CST 2018, time=2018-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=313886, encodeId=ebdf313886d6, content=好的, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/BHHqJOYCGO2Qnoy0HvW6a8484LMTViaaTLQricqaDrrg5shY907vventGeHZZgj5mlobGntCxX1JqYBgoEhLePCw/132, createdBy=a4312343135, createdName=guicaiwei, createdTime=Thu May 10 20:37:02 CST 2018, time=2018-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=313219, encodeId=eb0631321996, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/BHHqJOYCGO2Qnoy0HvW6a8484LMTViaaTLQricqaDrrg5shY907vventGeHZZgj5mlobGntCxX1JqYBgoEhLePCw/132, createdBy=a4312343135, createdName=guicaiwei, createdTime=Tue May 08 20:33:41 CST 2018, time=2018-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=312604, encodeId=e1a43126048f, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/BHHqJOYCGO2Qnoy0HvW6a8484LMTViaaTLQricqaDrrg5shY907vventGeHZZgj5mlobGntCxX1JqYBgoEhLePCw/132, createdBy=a4312343135, createdName=guicaiwei, createdTime=Sun May 06 18:29:57 CST 2018, time=2018-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1339081, encodeId=b4be133908116, content=<a href='/topic/show?id=447663054f5' target=_blank style='color:#2F92EE;'>#欧洲#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63054, encryptionId=447663054f5, topicName=欧洲)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEKxsKDoOOFxGpMibw6lsQFUIicWt7kWGevkdgFhjiban1icD2JdIBmjVo7qX7aSlCSpiaia382nuLKiaI3Cg/132, createdBy=5c442500150, createdName=ms9474365431325850, createdTime=Thu May 03 01:21:00 CST 2018, time=2018-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1385799, encodeId=2ffe1385e99d2, content=<a href='/topic/show?id=77371e08996' target=_blank style='color:#2F92EE;'>#Tagrisso#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17089, encryptionId=77371e08996, topicName=Tagrisso)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dcaa509, createdName=tsing_hit, createdTime=Thu May 03 01:21:00 CST 2018, time=2018-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=311220, encodeId=0e92311220da, content=很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/BHHqJOYCGO2Qnoy0HvW6a8484LMTViaaTLQricqaDrrg5shY907vventGeHZZgj5mlobGntCxX1JqYBgoEhLePCw/132, createdBy=a4312343135, createdName=guicaiwei, createdTime=Wed May 02 07:43:06 CST 2018, time=2018-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=310976, encodeId=7c133109e6c2, content=学习了.长知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Tue May 01 11:37:16 CST 2018, time=2018-05-01, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1714781, encodeId=9a4c1e14781c0, content=<a href='/topic/show?id=021230e312' target=_blank style='color:#2F92EE;'>#AZ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3073, encryptionId=021230e312, topicName=AZ)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Tue Oct 09 08:21:00 CST 2018, time=2018-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=313886, encodeId=ebdf313886d6, content=好的, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/BHHqJOYCGO2Qnoy0HvW6a8484LMTViaaTLQricqaDrrg5shY907vventGeHZZgj5mlobGntCxX1JqYBgoEhLePCw/132, createdBy=a4312343135, createdName=guicaiwei, createdTime=Thu May 10 20:37:02 CST 2018, time=2018-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=313219, encodeId=eb0631321996, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/BHHqJOYCGO2Qnoy0HvW6a8484LMTViaaTLQricqaDrrg5shY907vventGeHZZgj5mlobGntCxX1JqYBgoEhLePCw/132, createdBy=a4312343135, createdName=guicaiwei, createdTime=Tue May 08 20:33:41 CST 2018, time=2018-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=312604, encodeId=e1a43126048f, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/BHHqJOYCGO2Qnoy0HvW6a8484LMTViaaTLQricqaDrrg5shY907vventGeHZZgj5mlobGntCxX1JqYBgoEhLePCw/132, createdBy=a4312343135, createdName=guicaiwei, createdTime=Sun May 06 18:29:57 CST 2018, time=2018-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1339081, encodeId=b4be133908116, content=<a href='/topic/show?id=447663054f5' target=_blank style='color:#2F92EE;'>#欧洲#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63054, encryptionId=447663054f5, topicName=欧洲)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEKxsKDoOOFxGpMibw6lsQFUIicWt7kWGevkdgFhjiban1icD2JdIBmjVo7qX7aSlCSpiaia382nuLKiaI3Cg/132, createdBy=5c442500150, createdName=ms9474365431325850, createdTime=Thu May 03 01:21:00 CST 2018, time=2018-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1385799, encodeId=2ffe1385e99d2, content=<a href='/topic/show?id=77371e08996' target=_blank style='color:#2F92EE;'>#Tagrisso#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17089, encryptionId=77371e08996, topicName=Tagrisso)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dcaa509, createdName=tsing_hit, createdTime=Thu May 03 01:21:00 CST 2018, time=2018-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=311220, encodeId=0e92311220da, content=很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/BHHqJOYCGO2Qnoy0HvW6a8484LMTViaaTLQricqaDrrg5shY907vventGeHZZgj5mlobGntCxX1JqYBgoEhLePCw/132, createdBy=a4312343135, createdName=guicaiwei, createdTime=Wed May 02 07:43:06 CST 2018, time=2018-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=310976, encodeId=7c133109e6c2, content=学习了.长知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Tue May 01 11:37:16 CST 2018, time=2018-05-01, status=1, ipAttribution=)]
  7. [GetPortalCommentsPageByObjectIdResponse(id=1714781, encodeId=9a4c1e14781c0, content=<a href='/topic/show?id=021230e312' target=_blank style='color:#2F92EE;'>#AZ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3073, encryptionId=021230e312, topicName=AZ)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Tue Oct 09 08:21:00 CST 2018, time=2018-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=313886, encodeId=ebdf313886d6, content=好的, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/BHHqJOYCGO2Qnoy0HvW6a8484LMTViaaTLQricqaDrrg5shY907vventGeHZZgj5mlobGntCxX1JqYBgoEhLePCw/132, createdBy=a4312343135, createdName=guicaiwei, createdTime=Thu May 10 20:37:02 CST 2018, time=2018-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=313219, encodeId=eb0631321996, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/BHHqJOYCGO2Qnoy0HvW6a8484LMTViaaTLQricqaDrrg5shY907vventGeHZZgj5mlobGntCxX1JqYBgoEhLePCw/132, createdBy=a4312343135, createdName=guicaiwei, createdTime=Tue May 08 20:33:41 CST 2018, time=2018-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=312604, encodeId=e1a43126048f, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/BHHqJOYCGO2Qnoy0HvW6a8484LMTViaaTLQricqaDrrg5shY907vventGeHZZgj5mlobGntCxX1JqYBgoEhLePCw/132, createdBy=a4312343135, createdName=guicaiwei, createdTime=Sun May 06 18:29:57 CST 2018, time=2018-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1339081, encodeId=b4be133908116, content=<a href='/topic/show?id=447663054f5' target=_blank style='color:#2F92EE;'>#欧洲#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63054, encryptionId=447663054f5, topicName=欧洲)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEKxsKDoOOFxGpMibw6lsQFUIicWt7kWGevkdgFhjiban1icD2JdIBmjVo7qX7aSlCSpiaia382nuLKiaI3Cg/132, createdBy=5c442500150, createdName=ms9474365431325850, createdTime=Thu May 03 01:21:00 CST 2018, time=2018-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1385799, encodeId=2ffe1385e99d2, content=<a href='/topic/show?id=77371e08996' target=_blank style='color:#2F92EE;'>#Tagrisso#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17089, encryptionId=77371e08996, topicName=Tagrisso)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dcaa509, createdName=tsing_hit, createdTime=Thu May 03 01:21:00 CST 2018, time=2018-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=311220, encodeId=0e92311220da, content=很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/BHHqJOYCGO2Qnoy0HvW6a8484LMTViaaTLQricqaDrrg5shY907vventGeHZZgj5mlobGntCxX1JqYBgoEhLePCw/132, createdBy=a4312343135, createdName=guicaiwei, createdTime=Wed May 02 07:43:06 CST 2018, time=2018-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=310976, encodeId=7c133109e6c2, content=学习了.长知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Tue May 01 11:37:16 CST 2018, time=2018-05-01, status=1, ipAttribution=)]
    2018-05-02 guicaiwei

    很好

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=1714781, encodeId=9a4c1e14781c0, content=<a href='/topic/show?id=021230e312' target=_blank style='color:#2F92EE;'>#AZ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3073, encryptionId=021230e312, topicName=AZ)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Tue Oct 09 08:21:00 CST 2018, time=2018-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=313886, encodeId=ebdf313886d6, content=好的, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/BHHqJOYCGO2Qnoy0HvW6a8484LMTViaaTLQricqaDrrg5shY907vventGeHZZgj5mlobGntCxX1JqYBgoEhLePCw/132, createdBy=a4312343135, createdName=guicaiwei, createdTime=Thu May 10 20:37:02 CST 2018, time=2018-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=313219, encodeId=eb0631321996, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/BHHqJOYCGO2Qnoy0HvW6a8484LMTViaaTLQricqaDrrg5shY907vventGeHZZgj5mlobGntCxX1JqYBgoEhLePCw/132, createdBy=a4312343135, createdName=guicaiwei, createdTime=Tue May 08 20:33:41 CST 2018, time=2018-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=312604, encodeId=e1a43126048f, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/BHHqJOYCGO2Qnoy0HvW6a8484LMTViaaTLQricqaDrrg5shY907vventGeHZZgj5mlobGntCxX1JqYBgoEhLePCw/132, createdBy=a4312343135, createdName=guicaiwei, createdTime=Sun May 06 18:29:57 CST 2018, time=2018-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1339081, encodeId=b4be133908116, content=<a href='/topic/show?id=447663054f5' target=_blank style='color:#2F92EE;'>#欧洲#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63054, encryptionId=447663054f5, topicName=欧洲)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEKxsKDoOOFxGpMibw6lsQFUIicWt7kWGevkdgFhjiban1icD2JdIBmjVo7qX7aSlCSpiaia382nuLKiaI3Cg/132, createdBy=5c442500150, createdName=ms9474365431325850, createdTime=Thu May 03 01:21:00 CST 2018, time=2018-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1385799, encodeId=2ffe1385e99d2, content=<a href='/topic/show?id=77371e08996' target=_blank style='color:#2F92EE;'>#Tagrisso#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17089, encryptionId=77371e08996, topicName=Tagrisso)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dcaa509, createdName=tsing_hit, createdTime=Thu May 03 01:21:00 CST 2018, time=2018-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=311220, encodeId=0e92311220da, content=很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/BHHqJOYCGO2Qnoy0HvW6a8484LMTViaaTLQricqaDrrg5shY907vventGeHZZgj5mlobGntCxX1JqYBgoEhLePCw/132, createdBy=a4312343135, createdName=guicaiwei, createdTime=Wed May 02 07:43:06 CST 2018, time=2018-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=310976, encodeId=7c133109e6c2, content=学习了.长知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Tue May 01 11:37:16 CST 2018, time=2018-05-01, status=1, ipAttribution=)]
    2018-05-01 1ddf0692m34(暂无匿称)

    学习了.长知识

    0

相关资讯

ELCC 2016:Tagrisso一线治疗EGFR T790M突变NSCLC患者,PFS长达19.3个月

FDA在去年11月13日以加速批准的方式提前3个月批准了阿斯利康的Tagrisso(osimertinib,奥希替尼),用于二线治疗携带EGFR T790M突变的非小细胞肺癌(NSCLC)患者。FDA的批准依据是AURA项目中两项II期研究的结果,显示Tagrisso对接受EGFR抑制剂治疗后疾病恶化NSCLC患者的客观应答率(ORR)分别为57%和61%。所谓加速批准是FDA基于可预测药物临床获

AZ的Tagrisso对肺癌的治疗具有持续作用

阿斯利康公司表示,Tagrisso作为一线治疗肺癌的"前所未有的无进展生存获益"通过后续的治疗方案得以延续。根据对全球III期FLAURA试验的数据进行的新分析,该试验评估Tagrisso(osimertinib)作为局部晚期或转移性表皮生长因子受体(EGFR)突变阳性患者的第一线发作的有效性和安全性 (EGFR酪氨酸激酶抑制剂(TKIs),厄洛替尼或吉非替尼)的药物无进展存活(PFS)益处在整个

FDA对阿斯利康肿瘤治疗的Tagrisso进行优先审查

美国FDA已经开始对阿斯利康公司的一线非小细胞肺癌(NSCLC)的Tagrisso进行优先审查,并于2018年上半年获得批准。第三代EGFR抑制剂Tagrisso(osimertinib)已经被批准作为该类药物的后续治疗,包括AZ的易瑞沙(gefitinib)和罗氏的Tarceva(erlotinib),但扩大到一线使用可以显着提高其销售潜力。它也在11月向欧盟递交了一线用药申请,目前正在审核中。

欧洲药品管理局已经接受了Tagrisso(osimertinib)营销授权申请

阿斯利康宣布,欧洲药品管理局已经接受了Tagrisso(osimertinib)营销授权申请(MAAv)。Tagrisso是一种具有抗中枢神经系统(CNS)转移活性的第三代不可逆表皮生长因子受体(EGFR)酪氨酸激酶抑制剂(TKI),用于EGFR突变(外显子19缺失或外显子21(L858R)替换突变)局部晚期或转移性非小细胞肺癌(NSCLC)的一线治疗。MAAv提交是基于第三阶段FLAURA试验的

肺癌重磅消息!阿斯利康第三代靶向肺癌药物Tagrisso获中国CFDA批准

英国制药巨头阿斯利康(AstraZeneca)近日宣布,中国食品和药品监督管理总局(CFDA)已批准抗癌药Tagrisso(omisertinib,AZD9291)40mg和80mg片剂,作为一种每日口服一次的药物,用于既往接受表皮细胞生长因子受体(EGFR)酪氨酸激酶抑制剂(TKI)治疗期间或治疗后病情进展的局部晚期或转移性E

Baidu
map
Baidu
map
Baidu
map